Thiamine Administration Guidelines

Introduction to Thiamine Administration

The Korean Association for the Study of the Liver recommends thiamine administration via intramuscular (IM) or intravenous (IV) routes for patients at risk of thiamine deficiency, with a standard dose of 250 mg intramuscularly daily for 3-5 days 1

For alcoholic patients at risk of thiamine deficiency, an alternative dosing of 100-300 mg/day IM can be used, consistent with general parenteral dosing guidelines 1, 2
For established Wernicke's encephalopathy, higher doses of 500 mg three times daily are recommended, though IV route is preferred for this severe presentation 2, 3

Thiamine must be administered before any glucose-containing IV fluids to prevent precipitating acute Wernicke's encephalopathy in thiamine-depleted patients, with a recommended oral maintenance dose of 50-100 mg daily after the acute parenteral treatment phase 1, 2, 3, 4
The risk of anaphylactic shock from parenteral thiamine is less than 1 in 100,000, and this extremely low risk is far outweighed by the 20% acute mortality rate of untreated Wernicke-Korsakoff syndrome 2

After the acute parenteral treatment phase, patients should transition to 50-100 mg oral thiamine daily for maintenance, continuing for 2-3 months following resolution of withdrawal symptoms 1, 2
For patients who had documented Wernicke's encephalopathy, oral thiamine should be extended to 100-500 mg daily for 12-24 weeks 2, 4